X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-17 | ASMB | Gilead Sciences, Inc. | 10% | P - Purchase | $0.00 | +179,500 | 1,268,972 | +16% | +$0 | |||||
| D | 2024-04-02 | XLO | Gilead Sciences, Inc. | 10% | P - Purchase | $0.76 | +485,250 | 7,345,473 | +7% | +$368,790 | |||||
| D | 2024-02-12 | KYTX | Gilead Sciences, Inc. | 10% | P - Purchase | $22.00 | +910,000 | 4,126,119 | +28% | +$20,020,000 | |||||
2024-01-29 | RCUS | Gilead Sciences, Inc. | 10% | P - Purchase | $21.00 | +15,238,095 | 30,061,124 | +103% | +$319,999,995 | ||||||
2023-06-28 | RCUS | Gilead Sciences, Inc. | 10% | P - Purchase | $19.26 | +1,010,000 | 14,823,029 | +7% | +$19,452,600 | ||||||
2023-06-27 | ALVR | Gilead Sciences, Inc. | 10% | P - Purchase | $3.75 | +2,930,870 | 16,635,286 | +21% | +$10,990,763 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |